Canaan Partners XI’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Canaan Partners XI’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,051	Closed	-$487K	–	6
2023 Q1	$315K	Hold	37,051	–	–	0.23%	5
2022 Q4	$321K	Hold	37,051	–	–	0.25%	5
2022 Q3	$222K	Hold	37,051	–	–	0.09%	5
2022 Q2	$200K	Hold	37,051	–	–	0.07%	5
2022 Q1	$175K	Hold	37,051	–	–	0.07%	5
2021 Q4	$182K	Buy	+37,051	New	+$183K	0.05%	6

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canaan Partners XI's VECT Position: Q2 2023 in Review

Canaan Partners XI sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 37,051 shares — an estimated $487K sold.

Canaan Partners XI first reported a position in VECT in Q4 2021 and held it in 6 quarters. The position peaked at $321K in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Canaan Partners XI reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Canaan Partners XI sold 37,051 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $487K.
Canaan Partners XI first reported a position in VectivBio Holding AG Ordinary Shares in Q4 2021 and held it in 6 quarters.
Canaan Partners XI's VectivBio Holding AG Ordinary Shares position peaked at $321K in Q4 2022.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Canaan Partners XI's 13F filing for Q2 2023, filed 13 Jul 2023.